Obesity Surgery

, Volume 18, Issue 12, pp 1575–1580 | Cite as

Staged Laparoscopic Sleeve Gastrectomy Followed by Roux-en-Y Gastric Bypass for Morbidly Obese Patients: A Risk Reduction Strategy

  • Owen Ou Yang
  • Ken Loi
  • Victor Liew
  • Michael Talbot
  • John Jorgensen
Research Article

Abstract

Background

In our centre laparoscopic Roux-en-Y gastric bypass (LRYGBP) is the most effective weight loss surgical procedure performed. However, LRYGBP may be associated with higher risk of peri- and postoperative complications in contrast to a purely restrictive procedure to justify this procedure on all comers. Laparoscopic sleeve gastrectomy (LSG) as a staged procedure may be an alternate risk reduction strategy. The aim of this study is to report on the short-term outcomes of LSG, the effect on operative risk reduction and resolution of comorbidities.

Methods

A prospective review of 138 patients who underwent consecutive LSG from November 2004 to November 2006 was performed. Data were collected on all patients who attended the three to six monthly clinical follow-up and/or the patient questionnaire. Data collection included demographics, degree of weight reduction, postoperative complications, and changes in comorbidities.

Results

Median BMI was 50.60 kg/m2 (33–82). Of the patients, 46.38% had a BMI ≥50 kg/m2. The overall median postoperative excess weight loss (EWL) was 43.26%, 31.08% at 6 months, 54.50% at 12 months, 51.47% at 18 months and 46.05% at 24 months. Of the patients, 39% had resolution of type 2 diabetes mellitus, 48% had resolution of dyslipidemia, 29% in hypertension, 52% in obstructive sleep apnea. Complication rate was 5.07% and four patients needed further surgical intervention. The mortality rate was zero.

Conclusion

LSG does minimize postoperative complication rates significantly on high-risk patients and achieves effective short-term weight loss with resolutions in comorbidities. Additional studies are required to evaluate LSG as a stand-lone procedure.

Keywords

Laparoscopy Sleeve gastrectomy Morbid obesity LSG Risk reduction 

References

  1. 1.
    Cameron AJ, Welborn TA, Zimmet PZ, et al. Overweight and obesity in Australia: the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust. 2003;178:427–32.PubMedGoogle Scholar
  2. 2.
    National Health and Medical Research Council. Clinical practice guidelines for the management of overweight and obesity in adults. Canberra: NHMRC, September 2003. Available at: www.health.gov.au/internet/wcms/publishing.nsf/Content/obesityguidelines-guidelines-adults.htm/$FILE/adults.pdf (accessed Feb 2005). (July 2007).
  3. 3.
    Clegg A, Sidhu MK, Colquitt J, et al. Clinical and cost effectiveness of surgery for people with morbid obesity. Southampton: National Institute for Clinical Excellence, 2001. Available at: www.nice.org.uk/pdf/AssessmentReport-Surgeryforobesity.pdf (accessed Mar 2005). (July 2007).
  4. 4.
    NHS National Institute for Clinical Excellence. Guidance on the use of surgery to aid weight reduction for people with morbid obesity. Technology Appraisal Guidance No. 46. London: NICE, July 2002. Available at: www.nice.org.uk/pdf/Fullguidance-PDF-morbid.pdf (accessed Feb 2005).
  5. 5.
    US National Heart, Lung, and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Bethesda, MD: NHLBI, 1998. Available at: www.nhlbi.nih.gov/guidelines/obesity/ob_home.htm (accessed Feb 2005).
  6. 6.
    Talbot ML, Jorgensen JO, Loi KW. Difficulties in provision of bariatric surgical services to the morbidly obese. MJA. 2005;182(7):344–7.PubMedGoogle Scholar
  7. 7.
    Gallagher SF, Banasiak M, Gonzalvo JP, et al. The impact of bariatric surgery on the Veterans Administration healthcare system: a cost analysis. Obes Surg. 2003;13:245–8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12740132&dopt=Abstract \t 11.Google Scholar
  8. 8.
    Craig BM, Teng DS. Cost-effectiveness of gastric bypass for severe obesity. Am J Med. 2002;113:491–8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12427499&dopt=Abstract \t 12.Google Scholar
  9. 9.
    Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416–24.PubMedCrossRefGoogle Scholar
  10. 10.
    Sampalis JS, Liberman M, Auger S, Christou NV. The impact of weight reduction surgery on health-care costs in morbidly obese patients. Obes Surg. 2004;14:939–47.PubMedCrossRefGoogle Scholar
  11. 11.
    Ren CJ, Patterson E, Gagner M. Early results of laparoscopic biliopancreatic diversion with duodenal swetch: a case series of 40 consecutive patients. Obes Surg. 2000;10:514–23; discussion 524.PubMedCrossRefGoogle Scholar
  12. 12.
    Regan JP, Inabnet WB, Gagner M, et al. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;13:861–4.PubMedCrossRefGoogle Scholar
  13. 13.
    DeMaria et al. Validation of the Obesity Surgery Mortality Risk Score (OS-MRS) In A Multi-Center Study Proves It Stratifies Mortality Risk In Patients Undergoing Gastric Bypass (GBP) For Morbid Obesity. ASA: 2007 Abstracts. Colorado Springs.Google Scholar
  14. 14.
    Cottam D, Qureshi F, Mattar S, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006 Jun;20(6):859–63.PubMedCrossRefGoogle Scholar
  15. 15.
    Roa et al. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg. 2006;16:1323–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Han S, Kim, W, Oh J. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg. 2005;15:1469–75.CrossRefGoogle Scholar
  17. 17.
    Lewis, et al. Change in liver size and fat content after treatment with Optifast very low calorie diet. Obes Surg. 2006;16:697–701.PubMedCrossRefGoogle Scholar
  18. 18.
    Colles S, Dixon J, O’Brien P. A prospective study of the effect of a 12-week very low calorie diet on changes in health status, liver size and abdominal adipose tissue in the severely obese. Asia Pac J Clin Nutr. 2005;14 Suppl:S60.Google Scholar
  19. 19.
    Johnston D, et al. The magenstrasse and mill operation for morbid obesity. Obes Surg. 2003;13:10–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Liu JH, Zingmond D, Etzioni DA, O’Connell JB, Maggard MA, Livingston EH, et al. Characterizing the performance and outcomes of obesity surgery in California. Am Surgeon. 2003 Oct;69(10):823–8.PubMedGoogle Scholar
  21. 21.
    Hamoui N, Anthone G, Kaufman H, et al. Sleeve gastrectomy in the high-risk patient. Obes Surg. 2006;16:1445–9.PubMedCrossRefGoogle Scholar
  22. 22.
    Silecchia, et al. Effectiveness of laparoscopic sleeve gastrectomy (First Stage of Biliopancreatic Diversion with Duodenal Switch) on co-morbidities in super-obese high-risk patients. Obes Surg. 2006;16:1138–44.PubMedCrossRefGoogle Scholar
  23. 23.
    Milone K, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients. (BMI ≥50). Obes Surg. 2005;15:612–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Himpens J, Dapri G, Cadière G. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg. 2006;16:1450–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, LLC 2008

Authors and Affiliations

  • Owen Ou Yang
    • 1
    • 2
  • Ken Loi
    • 1
  • Victor Liew
    • 1
  • Michael Talbot
    • 1
  • John Jorgensen
    • 1
  1. 1.Upper GI, Advanced Laparoscopic and Bariatric SurgerySt George Private HospitalSydneyAustralia
  2. 2.SydneyAustralia

Personalised recommendations